These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3169092

  • 1. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
    Danova M, Riccardi A, Gaetani P, Wilson GD, Mazzini G, Brugnatelli S, Buttini R, Butti G, Ucci G, Paoletti P.
    Eur J Cancer Clin Oncol; 1988 May; 24(5):873-80. PubMed ID: 3169092
    [Abstract] [Full Text] [Related]

  • 2. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
    Giordano M, Riccardi A, Danova M, Brugnatelli S, Mazzini G.
    Cancer Detect Prev; 1991 May; 15(5):391-6. PubMed ID: 1751950
    [Abstract] [Full Text] [Related]

  • 3. Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry.
    Riccardi A, Danova M, Dionigi P, Gaetani P, Cebrelli T, Butti G, Mazzini G, Wilson G.
    Br J Cancer; 1989 Jun; 59(6):898-903. PubMed ID: 2736227
    [Abstract] [Full Text] [Related]

  • 4. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A, Danova M, Wilson G, Ucci G, Dörmer P, Mazzini G, Brugnatelli S, Girino M, McNally NJ, Ascari E.
    Cancer Res; 1988 Nov 01; 48(21):6238-45. PubMed ID: 3167869
    [Abstract] [Full Text] [Related]

  • 5. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
    Hoshino T, Ito S, Asai A, Shibuya M, Prados MD, Dodson BA, Davis RL, Wilson CB.
    Int J Cancer; 1992 Jan 02; 50(1):1-5. PubMed ID: 1728598
    [Abstract] [Full Text] [Related]

  • 6. Cell-kinetic characteristics of human brain tumors.
    Assietti R, Butti G, Magrassi L, Danova M, Riccardi A, Gaetani P.
    Oncology; 1990 Jan 02; 47(4):344-51. PubMed ID: 2367061
    [Abstract] [Full Text] [Related]

  • 7. Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
    Teodori L, Trinca ML, Goehde W, Hemmer J, Salvati F, Storniello G, Mauro F.
    Int J Cancer; 1990 Jun 15; 45(6):995-1001. PubMed ID: 2161804
    [Abstract] [Full Text] [Related]

  • 8. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y, Taomoto K, Saya H, Ijichi A, Kudo H, Kokunai T, Tamaki N, Matsumoto S.
    No To Shinkei; 1989 Apr 15; 41(4):383-90. PubMed ID: 2765301
    [Abstract] [Full Text] [Related]

  • 9. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T, Hoshino T.
    No Shinkei Geka; 1984 Aug 15; 12(9):1007-18. PubMed ID: 6390240
    [Abstract] [Full Text] [Related]

  • 10. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
    Benazzo M, Mevio E, Occhini A, Franchini G, Danova M.
    ORL J Otorhinolaryngol Relat Spec; 1995 Aug 15; 57(1):39-43. PubMed ID: 7700609
    [Abstract] [Full Text] [Related]

  • 11. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
    Margarino G, Scala M, Schenone G, Mereu P, Corvo R, Sanguineti G, Giaretti W, Geido E, Orecchia R, Meszaros P.
    Acta Otorhinolaryngol Ital; 1992 Aug 15; 12(5):421-33. PubMed ID: 1303006
    [Abstract] [Full Text] [Related]

  • 12. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
    Struikmans H, Rutgers DH, Jansen GH, Tulleken CA, van der Tweel I, Battermann JJ.
    Radiat Oncol Investig; 1997 Aug 15; 5(4):170-9. PubMed ID: 9327496
    [Abstract] [Full Text] [Related]

  • 13. Cell kinetics with in vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression, and flow cytometric analysis. Prognostic significance in acute nonlymphoblastic leukemia.
    Giordano M, Danova M, Mazzini G, Gobbi P, Riccardi A.
    Cancer; 1993 May 01; 71(9):2739-45. PubMed ID: 8096794
    [Abstract] [Full Text] [Related]

  • 14. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
    Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K.
    J Neurosurg; 1989 Mar 01; 70(3):379-84. PubMed ID: 2536805
    [Abstract] [Full Text] [Related]

  • 15. Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling.
    Shibuya M, Hoshino T, Ito S, Wacker MR, Prados MD, Davis RL, Wilson CB.
    Neurosurgery; 1992 Apr 01; 30(4):494-7; discussion 497-8. PubMed ID: 1584346
    [Abstract] [Full Text] [Related]

  • 16. Assessment of human tumour proliferation using bromodeoxyuridine--current status.
    Wilson GD.
    Acta Oncol; 1991 Apr 01; 30(8):903-10. PubMed ID: 1777243
    [Abstract] [Full Text] [Related]

  • 17. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
    Maeda T, Hoshino T.
    No To Shinkei; 1992 Sep 01; 44(9):821-5. PubMed ID: 1476811
    [Abstract] [Full Text] [Related]

  • 18. S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine.
    Hoshino T, Nagashima T, Cho KG, Murovic JA, Hodes JE, Wilson CB, Edwards MS, Pitts LH.
    Int J Cancer; 1986 Sep 15; 38(3):369-74. PubMed ID: 3527993
    [Abstract] [Full Text] [Related]

  • 19. Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine.
    Erba E, Giordano M, Danova M, Mazzini G, Ubezio P, Torri V, Mangioni C, Landoni F, Bolis P, Tenti P.
    Ann Oncol; 1994 Sep 15; 5(7):627-34. PubMed ID: 7993839
    [Abstract] [Full Text] [Related]

  • 20. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
    Asai A, Shibui S, Barker M, Vanderlaan M, Gray JW, Hoshino T.
    J Neurosurg; 1990 Aug 15; 73(2):254-8. PubMed ID: 2366082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.